Evaluating the costs, benefits and cost-effectiveness of multi-pathogen point-of-care tests for sexually transmitted infections
Modelling how point-of-care tests can enable personalised treatment for resistant gonorrhoea infections
Point-of-care tests for infectious diseases: Barriers to implementation across three London teaching hospitals
Point of care testing: Disruptive innovation – is the NHS ready for it yet?
How to prevent cervical cancer: HPV – we are coming to get you!
Estimating the clinical impact and costs of implementing a point of care test for influenza A/B and respiratory syncytial virus on an acute paediatric hospital inpatient ward
A rapid influenza test in hospitals could avoid unnecessary paediatric isolation bed days and save costs
Performance of a novel point-of-care molecular assay for the detection of Influenza A, B and RSV in children
Mapping the diagnostic pathway for breast cancer in England and comparison to Europe
Cervical screening and HPV testing: Opportunities for rapid tests
We explored the use of a rapid, on-demand human papillomavirus (HPV) test. Interviews with UK experts revealed that a co-located, on-demand HPV test following cytology could reduce the time to cervical screening results by up to a week, with a near-patient primary HPV test followed by cytology triage could radically change the testing paradigm. A follow-up tool we built in Excel was used to understand cervical screening burden and HPV testing across Europe.